RNA-binding protein with serine-rich domain 1 (RNPS1) is a component of pre-splicing and post-splicing multiprotein complexes, which activates constitutive and alternative splicing. RNPS1 participates in the formation of the spliceosome and activates the pre-mRNA splicing process. In the present study, we found that ubiquitin-specific protease 4 (USP4) is a binding partner of RNPS1. Although RNPS1 is polyubiquitinated by both K48-and K63-linkages, USP4 exclusively deubiquitinates K63-linked polyubiquitin chains of RNPS1. We also demonstrate that the catalytic activity of USP4 on ubiquitinated RNPS1 is elevated by squamous cell carcinoma antigen recognized by T cells 3 (Sart3).
processes [11] . First, noncoding sequences (introns) and coding sequences (exons) within entire genes are transcribed to produce mature mRNA in eukaryotes [12] . When RNA transcription is initiated by RNA polymerase, RNAs and protein are assembled by the spliceosome, which is composed of five core small nuclear ribonucleoproteins (snRNPs) (i.e. U1, U2, U4, U5 and U6 snRNPs) [13, 14] . Spliceosome assembly is initiated by splicing site recognition and activates premRNA splicing in general eukaryotic cells [15, 16] . Initially, the U1 snRNP recognizes mRNA 5 0 splice sites in the mRNA, followed by the U2 snRNP binding to the branch point [17] . Next, the U1 and U2 snRNPs recruit the U4/U6 di-snRNP and U5 snRNP sequentially, resulting in the pre-catalytic complex [17] . The U1 and U4 snRNPs are ejected from the pre-catalytic complex, and then the rest of the catalytic complex composed of the U2, U5 and U6 tri-snRNPs activates the spliceosome [18] . In this pathway, premRNA splicing is also supported from squamous cell carcinoma antigen recognized by T cells 3 (Sart3) via the recycling of U4/U6 di-snRNP [19] . In addition, Sart3 plays a central role in spliceosome cycle by regulating the significant pre-mRNA processing factor such as precursor RNA processing 3 (Prp3) [19, 20] .
As a result of the pre-RNA splicing catalysis, the introns are eliminated and the exons are linked [13] . Eukaryotic gene expression can be controlled by pre-RNA splicing with splicing factors such as serine/ arginine-rich (SR) proteins [21] . Most SR proteins play a key role in preserving splicing regulators as spliceregions for alternative splicing [12] . RNA-binding protein with serine-rich domain 1 (RNPS1), an SR protein, contains the serine-rich (S), RNA-recognition motif (RRM) and arginine/serine/proline-rich (RS/P) domains, which are well known motifs of splicing regulatory proteins [22] . The RRM domain is involved in specific binding of RNA, and the RS/P domain promotes protein-protein interactions [23, 24] . The RS domain in particular is an important region in selecting the splice site during splicing [22, 25, 26] and also aids to stabilize pre-mRNA splicing [27, 28] . SR proteins, including RNPS1, recruit U1 snRNPs that bind to splice sites and are important factors for promoting spliceosome catalysis by assembling snRNPs [29] . RNPS1, also known as an alternative splicing activator, has a crucial effect on pre-mRNA splicing via spliceosome activation [24, 27, 30, 31] . Activated RNPS1 contributes to splicing system operation by selecting exon-intron sites [16, 32] . Therefore, RNPS1 aids in selecting splicing sites and promotes pre-mRNA splicing by activating the spliceosome with snRNPs [24] . The splicing system influences cell proliferation, differentiation, signal transduction, cell cycle regulation, cell death, angiogenesis, invasiveness, motility and metastasis [33] [34] [35] . As a result, mutations in splicing factors can negatively affect various diseases [36] .
In the present study, RNPS1 was found to be regulated by the ubiquitin-proteasome pathway. RNPS1 was identified to interact with ubiquitin-specific protease 4 (USP4) as a novel binding partner. In a previous study, it was demonstrated that Sart3 binds to either USP4 or RNPS1 respectively [37, 38] . Taken together, it is concluded that ubiquitinated RNPS1 is regulated by the catalytic activity of USP4 along with Sart3 compared with USP4 alone.
Materials and methods

Yeast two-hybrid screening
To identify the novel binding partners for USP4, the yeast strain AH109 (Saccharomyces cerevisiae) containing reporter genes such as ADE2, HIS3, LACZ and MEL1 was used in a yeast two-hybrid Matchmaker GAL4 Two-Hybrid system 3 (Clontech, Palo Alto, CA, USA). Full-length human USP4 complementary DNA (cDNA) was subcloned into a pGBT9 vector containing a DNA-binding domain. To screen for new binding partners, a mouse brain cDNA library in pACT2 vector (Clontech) was used. pGBT9-USP4 and a cDNA library were co-transformed, plated on yeast extract-peptone-dextrose (YPD) plates, and cultured in YPD media that lacked leucine, tryptophan, histidine and adenine but contained 5-bromo-4-chloro-3-indoxyl-a-Dgalactopyranoside (X-a-gal) (Clontech). To identify nucleotide sequences, positive clones were picked and cultured in YPD media. Novel binding proteins were identified by sequencing and by a BLAST search. To confirm reciprocal interaction between USP4 and a novel binding protein, cotransformation of two constructs was performed with positive and negative controls into the AH109 yeast strain [39] .
Cell culture conditions and transfection
293T cells were grown in DMEM (Gibco BRL, Rockville, MD, USA) supplemented with 10% fetal bovine serum (Gibco BRL) and 1% penicillin and streptomycin (Corning Life Sciences, Tewksbury, MA, USA). Cells were transfected with plasmid DNAs in 100 mm culture dishes using 10 mM polyethylenimine reagent (Polysciences, Inc., Warrington, PA, USA).
Site-directed mutagenesis
USP4 (C311S) mutant construct was generated by using a QuikChange TM site-directed mutagenesis kit (Stratagene, La Jolla, CA, USA) in accordance with the manufacturer's instructions. PCR was performed at 95°C for 1 min, 59°C for 1 min, and 72°C for 16 min, for a total of 14 cycles. The forward primer (5 0 -CTG GGA AAC ACC AGC TTC ATG AAC TCC-3 0 ) and reverse primer (5 0 -GGA GTT CAT GAA GCT GGT GTT TCC CAG-3 0 ) were used to replace the cysteine at position 311 of USP4 with a serine (UbiProtein Corp, Seongnam, South Korea).
Antibodies
Anti-Myc, anti-b-actin and anti-His-probe H3 monoclonal antibodies were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA) (mouse monoclonal; dilution 1 : 1000). An anti-USP4 antibody was purchased from Santa Cruz Biotechnology (mouse polyclonal; dilution 1 : 1000). An anti-Flag antibody was purchased from MBL (Nagoya, Japan) (mouse monoclonal; dilution 1 : 1000). An anti-HA antibody (12CA5) was purchased from Roche (Basel Switzerland) (mouse polyclonal; dilution 1 : 1000). An anti-RNPS1 antibody was purchased from GeneTex (Irvine, CA, USA) (rabbit polyclonal; dilution 1 : 1000). An Easy Blot antibody was purchased from GeneTex (mouse polyclonal; dilution 1 : 1000). Anti-K48-and anti-K63-linkage specific ubiquitin antibodies were purchased from Cell Signaling (Danvers, MA, USA) (rabbit monoclonal; dilution 1 : 1000).
Glutathione S-transferase pull-down assay
To perform the glutathione S-transferase (GST) pull-down assay, GST-RNPS1 was generated via subcloning from pCS4-3Flag-RNPS1 to pGEX-4T-1-RNPS1. Escherichia coli BL21 (DE3) cells transformed with an expression vector for GST-RNPS1 were grown until A 600 of 0.6-0.8 was reached and induced with 0.2 mM isopropyl thio-b-D-galactoside and 0.01% EtOH at 18°C for 22 h. Purified GST-RNPS1 protein from E. coli BL21 cells was incubated with GST-Bind Agarose Beads (ElpisBio, Daejeon, Korea) for 4 h at 18°C. The beads were then washed with a washing buffer (0.1 M Tris-HCl at pH 7.4, 0.5 M NaCl, 20 mM imidazole at pH 7.4). Protein was successfully eluted from beads by boiling with 2 9 SDS buffer followed by western blotting using an anti-Myc antibody (mouse monoclonal; dilution 1 : 1000; Santa Cruz Biotechnology) [40, 41] .
His pull-down assay
To perform the His pull-down assay, Myc-USP4, Flag-RNPS1 and pQE-His-ubiquitin were co-transfected into 293T cells. These cells were lysed in urea buffer (8 M urea, 100 mM Na 2 HPO 4 , 0.2% Triton X-100, 10 mM imidazole and 10 mM Tris-HCl at pH 8.0) after 48 h of transfection. Cell lysates were incubated with His-Bind Agarose Beads (ElpisBio) for 4 h at room temperature. These beads were washed using pre-washing buffer (8 M urea, 100 mM Na 2 HPO 4 , 0.2% Triton X-100, 10 mM imidazole and 10 mM Tris-HCl at pH 6.3) and washing buffer (100 mM NaCl, 20% glycerol, 10 mM imidazole and 20 mM Tris-HCl at pH 8.0). Western blotting was performed using an antiHis-probe H3 antibody (mouse monoclonal; dilution 1 : 1000, Santa Cruz Biotechnology).
Immunoprecipitation and western blot analysis
Cells were incubated for 24 h after transfection and were then lysed in lysis buffer (20 mM Tris-HCl at pH 7.5, 150 mM NaCl, 1 mM EDTA, 10% glycerol, 1% Triton X-100, 100 mM phenylmethanesulfonyl fluoride and protein inhibitor cocktail). Whole cell lysates were incubated with an anti-Flag antibody (mouse monoclonal; dilution 1 : 1000; MBL) or an anti-Myc antibody (mouse monoclonal; dilution 1 : 1000; Santa Cruz Biotechnology) at 4°C overnight. Protein A/G PLUS-agarose beads (Santa Cruz Biotechnology) were added to the lysates and incubated at 4°C for 2 h. The beads were washed twice and eluted by boiling with 2 9 SDS buffer. For western blotting, eluted samples or lysates were loaded onto 10% SDS/PAGE gels and were transferred onto PVDF (polyvinylidene fluoride) membranes (Millipore Corporation, Bedford, MA, USA). The membranes were blocked in 5% skim milk and were used for immunoprecipitation (IP) using anti-Flag (mouse monoclonal; dilution 1 : 1000; MBL), anti-Myc (mouse monoclonal; dilution 1 : 1000; Santa Cruz Biotechnology), anti-RNPS1 (rabbit polyclonal; dilution 1 : 1000; GeneTex), anti-HA (12CA5) (mouse polyclonal; dilution 1 : 1000; Roche) and anti-K48-and anti-K63-linkage specific ubiquitin antibodies (rabbit monoclonal; dilution 1 : 1000; Danvers). The immunoblotted bands were detected using an X-ray developer and by exposure to a film. To adjust the western blot results, quantification by IMAGEJ (NIH, Bethesda, MD, USA) and PRISM, version 5 (Graphpad Software, San Diego, CA, USA) was performed with at least three independent experiments. The intensity of specific bands from western blotting was quantified by densitometric analysis and is represented as the relative expression level compared with that of a control [42, 43] .
Ubiquitination and deubiquitination assays
For the ubiquitination assay of RNPS1, cells are transfected with Flag-RNPS1 and HA-ubiquitin and then incubated for 24 h. For the deubiquitination assay of RNPS1, cells were transfected with Flag-RNPS1, Myc-USP4, Myc-USP4 (C311S) and HA-ubiquitin and then incubated for 24 h. Subsequently, incubated cells were lysed in a lysis buffer (20 mM Tris-HCl at pH 7.5, 150 mM NaCl, 1 mM EDTA, 10% glycerol, 1% Triton X-100, 100 mM PMSF and protein inhibitor cocktail). For the IP assay, whole cell lysates were incubated with an anti-Flag (mouse monoclonal; dilution 1 : 1000; MBL) or an anti-RNPS1 (rabbit polyclonal; dilution 1 : 1000; GeneTex) antibody at 4°C overnight. Furthermore, protein A/G PLUS-agarose beads (Santa Cruz Biotechnology) were added and incubated at 4°C for 2 h. The beads were washed and eluted by boiling with 2 9 SDS buffer. These samples were used for western blotting with anti-Flag (mouse monoclonal; dilution 1 : 1000; MBL), anti-Myc (mouse monoclonal; dilution 1 : 1000; Santa Cruz Biotechnology) and anti-HA (12CA5) (mouse polyclonal; dilution 1 : 1000; Roche) antibodies.
Results
Identification of RNPS1 as a new binding partner of USP4
The RNPS1 was identified as a novel binding partner of USP4 via yeast two-hybrid screening. To confirm the specific binding between USP4 and RNPS1 in vivo, yeast mating experiments were performed with positive and negative controls (Fig. 1A ). Co-expression of the Gal4 DNA binding domain (Gal4-DBD)-USP4 and Gal4 activation domain (Gal4-AD)-RNPS1 in the yeast strain AH109 resulted in blue colonies. Fusion between the Gal4-DBD-p53 and Gal4-AD-SV-40 large T-antigen (SV40 T) generated the blue colonies as a positive control. On the other hand, Gal4-DBD did not bind to RNPS1 and Gal4-AD had no affinity for USP4. The interaction between Gal4-DBD and Gal4-AD did not result in any colony formation (Fig. 1B) .
USP4 binds to RNPS1
To confirm the interaction between USP4 and RNPS1, 293T cells were transfected with Myc-USP4 and Flag-RNPS1 for an IP assay. confirmed ( Fig. 2A) . Next, to demonstrate endogenous protein binding, a co-immunoprecipitation (co-IP) assay was performed using anti-USP4 and anti-RNPS1 antibodies (Fig. 2B) . Furthermore, to identify the direct interaction between USP4 and RNPS1, the GST pull-down assay was performed (Fig. 2C) . The results revealed that RNPS1 directly interacts with USP4.
To determine the exact binding sites, truncated forms of RNPS1 were generated. Full-length RNPS1 has the S, the RRM and RS/P domains (Fig. 3A) . The N-terminal truncated form of RNPS1 contains the S domain. The C-terminal truncated form of RNPS1 contains the RRM and RS/P domains, which are essential modulating regions during splicing [22] . A co-IP assay between full-length USP4 and truncated forms of RNPS1 was performed (Fig. 3B) . Full-length USP4 interacted with both the N-terminal (S domain) and C-terminal regions (RRM and RS/P domains). The results revealed that USP4 interacts with the S, RRM and RS/P domains. In addition to this, co-IP assays between the full-length RNPS1 and truncated forms of USP4 were also performed. Fulllength USP4 is composed of the domain present in ubiquitin-specific proteases (DUSP), ubiquitin-like 1 (UBL1), ubiquitin-like 2 (UBL2) and UCH domains (Fig. 3C) . Full-length RNPS1 binds to USP4 throughout these domains (Fig. 3D) . The result confirmed that RNPS1 binds to the DUSP, UBL1, UBL2 and UCH domains.
RNPS1 is influenced by the ubiquitin pathway
The present study revealed that RNPS1 is attached to ubiquitin molecules. The ubiquitination level of RNPS1 is accumulated by the ubiquitin-proteasome pathway when treated with MG132, a proteasome inhibitor (Fig. 4A) . This result demonstrated that RNPS1 undergoes the ubiquitin-mediated degradation. Polyubiquitination has very diverse roles in cells. K48-linked polyubiquitin chains are related to protein degradation by 26S proteasome, whereas K63-linked polyubiquitin chains are associated with functional pathways such as protein-protein interaction or the modulation of protein kinases [44] . To identify the ubiquitination pattern of RNPS1, mutant ubiquitin constructs were used [1] . A schematic diagram indicates that lysine residues of ubiquitin were replaced with arginine (K48R and K63R) (Fig. 4B, right) . The results confirmed that polyubiquitin chains exist on RNPS1 with both mutated K48 and K63 (Fig. 4B , left). It could also be confirmed that polyubiquitin chains of RNPS1 are formed by various lysine-linked polyubiquitin chains. Thus, other mutant ubiquitin constructs (R48K and R63K) were used to specifically confirm the lysine-specific-linked polyubiquitin chains of RNPS1. A schematic diagram shows that all lysine residues of ubiquitin replaced with arginine were later resubstituted with lysine (R48K and R63K) (Fig. 4C,  right) . Consequentially, it was confirmed that RNPS1 is affected by both K48-and K63-linked polyubiquitination (Fig. 4C, left) . This indicates that conjugating RNPS1 with ubiquitin results in degradation by the 26S proteasome and has a connection with proteasome-independent functions. Ubiquitinated RNPS1 is significantly increased by MG132 (Fig. 4A , lane 5) compared with the amount of K48-linked polyubiquitin chains of RNPS1 (Fig. 4C, lane 4) . However, when MG132 was treated, it is possible that the total ubiquitination could be increased not only by K48-linked polyubiquitin chains, but also any other polyubiquitin chains including K11-linked polyubiquitin chains. Also, differential accumulation of total ubiquitinated RNPS1 in a dose-dependent manner of MG132 was shown (see Fig. S1 ). This explains that the total accumulated ubiquitination level of RNPS1 could be affected by the MG132 concentration. Furthermore, differential polyubiquitin chains of RNPS1 were observed in the presence of MG132 (Fig. 4D ). When treated with MG132, both total ubiquitin chains and K48-linked polyubiquitin chains of RNPS1 were increased, whereas K63-linked polyubiquitin chains of RNPS1 hardly changed, indicating that K63-linked polyubiquitin chains are not associated with ubiquitinmediated degradation [45] .
RNPS1 is modulated by USP4
Based on binding between USP4 and RNPS1, the deubiquitination assay of RNPS1 using wild-type USP4 and a catalytically inactive mutant USP4 (C311S) was performed. Ubiquitination patterns of endogenous RNPS1 were suppressed by overexpression of the wildtype USP4 but were not inhibited by the mutant USP4 (C311S) (Fig. 5A) . Ubiquitination of exogenous RNPS1 bound to USP4 was reduced compared with the ubiquitination level of RNPS1 alone (Fig. 5B) . Wild-type USP4 was found to influence the ubiquitination level of RNPS1 via its DUB activity compared with RNPS1 ubiquitination with a catalytically inactive form of USP4 (C311S). Furthermore, to observe the ubiquitin attached to RNPS1 in denaturing conditions, a His pull-down assay using His-ubiquitin was carried out (Fig. 5C) . Next, to observe the deubiquitination of RNPS1 by USP4, the deubiquitination assay of RNPS1 using various doses of Myc-USP4 was performed [43] . As the dose of USP4 was gradually increased, the ubiquitination level of RNPS1 was decreased (Fig. 5D) . The results obtained suggest that RNPS1 is deubiquitinated by USP4. To determine whether USP4 regulates K48-or K63-linked polyubiquitin chains of RNPS1, the deubiquitination assay of RNPS1 was performed using mutant constructs of ubiquitin (R48K and R63K) (Fig. 5E ). K63-linked polyubiquitin chains of RNPS1 were deubiquitinated by the catalytic activity of USP4, although K48-linked polyubiquitin chains did not show such deubiquitination. Furthermore, the deubiquitination assay of RNPS1 was performed using anti-K48-and anti-K63-linkage specific ubiquitin antibodies (Fig. 5F ). The results obtained indicate that RNPS1 is deubiquitinated at its K63-linkages by USP4. In conclusion, it is shown that polyubiquitin chains of RNPS1 are formed through both K48-and K63-linkages, although the level of K63-linked polyubiquitination of RNPS1 is decreased by the catalytic activity of USP4. 
RNPS1 is not stabilized by USP4
It is expected that USP4 would not regulate the stabilization of RNPS1 because there is no effect on K48-linked polyubiquitin chains of RNPS1. To evaluate RNPS1 stabilization, RNPS1 protein levels were examined upon transfecting Myc-USP4 in a dose-dependent manner. With the increased expression level of USP4, the expression of endogenous RNPS1 was not changed (Fig. 6A) . The levels of USP4 and RNPS1 were quantified using IMAGEJ and PRISM, version 5 (Graphpad Software). Statistical analysis with Tukey's multiple comparison test was performed (Fig. 6B) . The result obtained indicates that RNPS1 was targeted by USP4 as a specific DUB, although USP4 would be related to functional signalling rather than the regulation of RNPS1 stability.
USP4-Sart3 complex is more DUB-efficient compared with USP4 alone on ubiquitinated RNPS1
In a previous study, it was confirmed that USP4 is associated with RNA splicing mechanisms [37] . In this process, Prp3 is a major component of the U4/U6 disnRNP that regulates the spliceosome composition [37, 46] . A previous study demonstrated that Prp3 attached to ubiquitin goes through the ubiquitin-proteasome pathway and is deubiquitinated by USP4 [37] . Polyubiquitin chains on Prp3 are formed on K63-rather than K48-linkages, indicating functional regulation in RNA splicing [37] . K63-linked polyubiquitin chains on Prp3 are related to the stabilization of U4/U6/U5 tri-snRNP and the spliceosome assembly [37] . USP4 affects RNA splicing by controlling K63-linked polyubiquitin chains on Prp3. Furthermore, the interaction between USP4 and Prp3 is enhanced by Sart3, which is known to be an U4/U6 spliceosome recycling factor and promotes the deubiquitination of Prp3 [37, 47] . Activation of splicing is determined by the separation of U1 and U4 snRNPs from the precatalytic complex containing U1, U2, U4/U6 and U5 snRNPs. Therefore, Prp3 deubiquitinated by USP4-Sart3 is released from U5 and U6 snRNPs, which subsequently contributes to accurate splicing [37] . Healthy splicing is an essential step in most eukaryotic cells as a result of the need for the normal production of mature RNA and its diverse generation [48] . A previous study showed that Sart3 also binds to RNPS1 [38] . In the present study, it was shown that RNPS1 is deubiquitinated by USP4. Therefore, it is predicted that Sart3 supports the binding between USP4 and RNPS1 and then promotes the deubiquitination of RNPS1. Hence, it was reconfirmed that Sart3 binds to both USP4 and RNPS1 (Fig. 7A) . To confirm the hypothesis, a binding assay between USP4-Sart3 and RNPS1 was performed using Flag-RNPS1, Myc-USP4 and Myc-Sart3 (see Fig. S2 ). The deubiquitination assay of RNPS1 was also performed using Flag-RNPS1, HA-ubiquitin, Myc-USP4 and Myc-Sart3 (Fig. 7B) . The results obtained showed that Sart3 enhances the DUB activity of USP4 on ubiquitinated RNPS1 proteins but does not influence an interaction between USP4 and RNPS1. Consequently, ubiquitinated RNPS1 is deubiquitinated more efficiently by the USP4-Sart3 complex compared with USP4 alone (Fig. 7B ).
Discussion
In eukaryotic cells, most genes consist of exons containing genetic information and introns with noncoding information that may undergo the pre-mRNA splicing process [49] . After processing, the exons join together without the introns and the gene is finally To examine the stability of RNPS1 by USP4, Myc-USP4 was transfected into 293T cells at various doses. Western blotting was performed using anti-Myc and anti-RNPS1 antibodies. As the expression of USP4 was gradually increased, the levels of endogenous RNPS1 were not changed, although RNPS1 stability was not modulated by USP4. (B) Quantification of Myc-USP4 and RNPS1 levels through the statistical analysis. These results represent that RNPS1 stability was not regulated by USP4 as a DUB (n = 3, not significant).
expressed [48] . The pre-mRNA splicing is involved in its maturation and is important for expression of diverse genes by selecting the splice site [26] . The constitutive and alternative splicing is activated by SR proteins that promote spliceosome assembly by recognizing splice sites and recruiting splicing factors [26] . This is a normal process but abnormal splicing leads not only to altered gene expression, but also to the development of cancer or other diseases [36] . In addition to this, aberrant splicing provokes tumor suppressor genes such as tumor protein p53 (TP53), AT-Rich interaction domain 1A (ARID1A) and von HippelLindau (VHL) [50] . Furthermore, alternative splicing correlates with all the characteristics of cancer: apoptosis evasion, immune system inactivation, invasion and metastasis progression, angiogenesis activation, cellular state disruption, growth in the absence of growth factors, constant cell proliferation, and upregulation of pluripotency [48] . Therefore, inappropriate splicing produces unsuitable spliced forms that can cause cancerous growth [48, 51] . Consequently, disruptions in various SR proteins have a negative effect on accurate splicing [49] . SR proteins play a significant role in pre-mRNA splicing because diverse SR proteins including serine/arginine-rich splicing factor 1 (SRSF1), SC35, hTra2a and RNPS1 regulate premRNA splicing by affecting transcription, mRNA export, genome stability, nonsense-mediated decay and translation [12, 52] . However, the roles of RNPS1 during splicing have not yet been completely clarified. USP4 is an attractive DUB involved in a variety of cellular mechanisms. USP4 overexpression is correlated with numerous types of cancer because it deubiquitinates ubiquitin-conjugated proteins. Therefore, USP4 is related to different aspects of cancer as an indispensable DUB by regulating cellular signalling. USP4 affects neuronal apoptosis in the intracerebral hemorrhage pathway [53] , which could be correlated with human breast cancer migration and invasion by promoting relaxin/transforming growth factor-b1/ Smad2/matrix metallopeptidase 9 signalling [54] , and also modulates the activation of transforming growth factor b-activated kinase 1-(JNK1/2)/p38 signalling in cardiac hypertrophy [55] . In addition, it influences bcatenin stabilization to affect metastatic potential [56] , modulates the antiviral response by regulating retinoic acid-inducible gene I [57] and correlates with colorectal oncogenesis by regulating phosphatase of regenerating liver-3 [58] . Furthermore, USP4 has important roles in DNA-end resection and DNA repair [4] , p53 and NF-jB signalling [59] , homologous recombination [60] and DNA double-strand breaks [61] . Wnt/b-catenin signalling is a significant pathway in osteoblast differentiation and is also modulated by USP4 [62, 63] . Recently, it was found that USP4 interacts with programmed cell death 4, thereby repressing cell proliferation in breast cancer cells [64] . Therefore, overexpressed USP4 has proper or improper functions in several cell lines and influences multiple types of disease.
In the present study, it was observed that (i) USP4 is a novel binding partner of RNPS1; (ii) RNPS1 is susceptible to K48-and K63-linked polyubiquitination; (iii) USP4 deubiquitinates K63-linked polyubiquitin chains of RNPS1; (iv) it is possible that USP4 could be associated with RNA splicing by disassembling the K63-linked polyubiquitin chains of RNPS1; and (v) Sart3 promotes the DUB activity of USP4 on ubiquitinated RNPS1. To identify the functional mechanism between USP4 and RNPS1, studies at the molecular and cellular levels should be conducted.
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